CMPX

Conviction 69HealthcareScan · Mon, Aug 10, 2026

CMPX$2.23+3.72%

ResistanceSupportVol 14

Vol MA14 3.83M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Compass Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.compasstherapeutics.com ↗

Price2.23

Change+3.72%

Gap+0.00%

Rel volume4.59×

Avg volume3.24M

Avg $ vol6.67M

SMA 202.04

SMA 502.10

SMA 2004.15

Price vs 50+6.28%

Price vs 200-46.23%

MA stackmixed

50/200 cross—

Supertrendup · 1.81

RSI (14)59

MACD hist0.02

MACD crossbull · 1d

Stoch %K / %D100 / 72

ADX (14)18

+DI / −DI23 / 17

RSI divergence—

MACD divergence—

ATR %+5.46%

ADR %5.30%

52w high6.69

52w low1.67

From 52w high-66.67%

Above 52w low+33.53%

New 52w highNo

SqueezeOff

Bollinger width18.91%

%B0.98

Donchian pos92.68%

Donchian high2.26

Donchian low1.85

AVWAP (52w high)2.73

vs AVWAP high-18.36%

AVWAP (52w low)1.99

vs AVWAP low+12.31%

OBV trendFlat

Chaikin MF (20)0.17

Today vs 20d4.59×

Avg vol (14d)3.83M

Avg vol (20d)3.24M

Avg $ vol (20d)6.67M

Market cap401.6M

RS 3m (vs SPY)+13.09%

RS 6m (vs SPY)-79.55%

RS line new highNo

Trend template3/8

Technical rank26.3

1 week+18.30%

1 month-4.29%

3 months+21.86%

6 months-65.80%

1 year-19.78%

YTD-56.87%

P/E-6.04

P/B2.42

P/S—

P/FCF-8.17

EPS-1.31

Div yield—

ROE-40.04%

ROA-34.96%

Debt/Eq0.00

Current11.22

EV/EBITDA-5.07

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-34.66%

Price target9.33

Target upside318.39%

Analyst ratingBuy

Institutional104.34%

Ent. value366.14M

Revenue0

Net income-25.15M

Gross profit—

Free cash flow-49.17M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out180.09M

Employees39

ListedFri, Nov 13, 2020

Free float96.72M

Float %54.4%

Short interest39.3M

Days to cover15.7d

Short volume46.5%

Squeeze score84 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.13 vs −$0.10

Last surprise-30.0% miss

Setup gradeB

Conviction69 / 100

Pattern quality—

Tech rank26.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.36

Support1.85

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CMPX

All disclosures →

No recent disclosed trades by Congress in CMPX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CMPX · 2 buys

Insider	Side	Shares	Value	Traded	Filed
Anderman Jonathan General Counsel · Common Stock · 2026-04-29	Grant	25K	$47K	2026-04-29	2026-04-29
Lerner Neil Chief Accounting Officer · Common Stock · 2026-04-29	Grant	15K	$28K	2026-04-29	2026-04-29

SEC filings

EDGAR filings in CMPX · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.